From January 1, 2024 to January 11, 2024, the company has repurchased 1,049,800 shares, representing 0.22% for CNY 60 million. With this, the company has completed the repurchase of 1,696,800 shares, representing 0.36% for CNY 99.99 million under the buyback announced on December 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.35 CNY | -4.84% | -14.49% | -38.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.71% | 2.46B | |
-19.14% | 8.22B | |
+48.66% | 3.73B | |
-8.06% | 2.46B | |
-8.84% | 2.36B | |
-9.02% | 1.78B | |
-19.29% | 1.52B | |
-40.78% | 1.21B | |
+8.32% | 1.12B | |
-12.27% | 1.09B |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.